The current valuation score of iBio Inc is 7.32, ranking 243 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.00, which is -224.86% below the recent high of 3.75 and -67708.70% above the recent low of -2035.75.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.